Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells

References

Page 1

	Year	Citations
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials R. Garg JAMA HypertensionHeart FailureAce InhibitorsCardiovascular DiseaseAntihypertensive Therapy	1995	1.5K
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Mat J.A.P. Daemen, Donna M. Lombardi, Fred T. Bosman, Circulation Research MechanobiologyHypertensionAngiogenesisAngiotensin IiCardiovascular Disease	1991	741
Angiogenesis. PubMed	1992	731
Microvessel quantitation and prognosis in invasive breast carcinoma Silvano Bòsari, Arthur K.C. Lee, Ronald A. DeLellis, Human Pathology Breast OncologyMicrovessel QuantitationMedicineBreast ImagingBreast Cancer	1992	556
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. Rajiv Garg, Salim Yusuf PubMed	1995	551
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Anthony F. Lever, David Hole, C. Gillis, The Lancet Inhibitory ActivityOncologyMedicinePathologyPharmacotherapy	1998	545
Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide Hideo Kimura, Alessandro Weisz, Yukiko Kurashima, Blood	2000	429
Neovascularization produced by angiotensin II. Fernandez La, Jeff Twickler, A Mead PubMed	1985	389
Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms Elisabeth L. Pagé, Geneviève Robitaille, Jacques Pouysségur, Journal of Biological Chemistry	2002	384
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. Olga V. Volpert, William F. Ward, Mark W. Lingen, Journal of Clinical Investigation Cellular PharmacologyPharmacotherapyTumor BiologyMolecular PharmacologyExperimental Tumors	1996	331

Page 1